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Abstract 
 
Quantitative analysis using proton NMR (1H qNMR) has been employed in various areas such as 
pharmaceutical analysis (e.g., dissolution study), vaccines, natural products analysis, metabolites, 
and macrolide antibiotics in agriculture industry. However, it is not routinely used in the 
quantification of saccharides in dry powder inhaler (DPI) formulations. The aim of this study was to 
develop a 1H NMR method for the quantification of saccharides employed in DPI formulations. Dry 
powders as DPI carriers were prepared by spray drying (SD) and spray freeze drying (SFD) using three 
saccharides: namely D-mannitol, D-sorbitol and D-(+)-sucrose. The calibration curves constructed for 
all three saccharides demonstrated linearity with R2 value of 1. The 1H qNMR method produced 
accurate (relative error %: 0.184-3.697) and precise data with high repeatability (RSD %: 0.517-
3.126) within the calibration curve concentration range. The 1H qNMR method also demonstrated 
significant sensitivity with low values of limit of detection (0.058 mM for D-mannitol, 0.045 mM for 
D-(+)-sucrose, and 0.056 mM for D-sorbitol) and limit of quantitation (0.175 mM for D-mannitol, 
0.135 mM for D-(+)-sucrose, and 0.168 mM for D-sorbitol). Pulmonary deposition via impaction 
experiments of the three saccharides was quantified using the developed method. It was found that 
SFD D-mannitol (68.99%) and SFD D-(+)-sucrose (66.62%) exhibited better delivered dose (total 
saccharide deposition in throat and all impactor stages) than SD D-mannitol (49.03%) and SD D-(+)-
sucrose (57.70%) (p< 0.05). The developed 1H qNMR methodology can be routinely used as an 
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analytical method to assess pulmonary deposition in impaction experiments of saccharides 
employed as carriers in DPI formulations. 
 
Keywords: Quantitative NMR, Saccharides, Dry powder inhaler formulation, Lung deposition, Spray 
drying, Spray freeze drying 
 
 
 
1. Introduction 
 
During the development of DPI formulations, only small amounts of drugs are used; therefore, the 
overall DPI performance is dependent on the excipients (Pilcer, and Amighi, 2010; Rahimpour, 
Kouhsoltani and Hamishehkar, 2014). Therapeutic efficacy of DPI formulations is dependent on the 
amount of the drug dose that reach the lungs (Yang, Chan and Chan, 2014; Ali and Gary, 2015). In the 
development of carrier based DPI formulations, carrier physicochemical properties such as particle 
size distribution and surface properties have a significant effect on the drug aerosolisation efficiency 
and affect the deposition pattern of the therapeutic drug in the lungs (Hamishehkar et al., 2010; Pilcer, 
and Amighi, 2010; Kaialy and Nokhodchi, 2012; Rahimpour, Kouhsoltani and Hamishehkar, 2014; Ali 
and Gary, 2015; Banga, 2015; Peng et al., 2016). The deposition patterns of carriers in the respiratory 
system are an important aspect of the formulation process during the development phase. Anatomical 
and physiological variabilities within subjects, who have different airways geometry and inhalation 
profiles (e.g., inspiratory flow rate) also influence the deposition pattern resulting in inconsistent lung 
drug delivery and poor DPI formulation performance (Depreter, Pilcer and Amighi, 2013; Ung et al., 
2014; Ali and Gary, 2015; Banga, 2015). It is difficult to measure the drug dose deposition and the 
distribution of the aerosolised particle deposition in the lungs in vivo. This leads to limited knowledge 
of the aerosolised DPI formulation performance under real clinical conditions (Ung et al., 2014; Ali and 
Gary, 2015). The particle size distribution of the aerosolised dry powders dispersed from a DPI is 
generally studied in vitro using an impactor such as a next generation impactor (NGI) (Ung et al., 2014; 
Ali and Gary, 2015). The NGI has seven stages (1-7) and a micro orifice collector (MOC) arranged in 
descending cut-off aerodynamic particle size order that separates the largest particles first and pass 
through the smaller particles to the next NGI stage and determines particle size distributions in vitro 
(D’Addio et al., 2013; Ali and Gary, 2015). The aerosolisation performance of DPI formulations is 
assessed by mass median aerodynamic diameter (MMAD) along with geometric standard deviation 
(GSD), fine particle dose (FPD) and fine particle fraction (FPF). MMAD is defined as the aerodynamic 
diameter at which 50% of total particles by mass (Niwa, Mizutani and Danjo, 2012) and GSD is 
expressed as a degree of an aerodynamic particle size distribution (Razavi Rohani, Abnous and 
Tafaghodi, 2014; Ali and Gary, 2015). FPD is defined as the amount of the delivered drug dose with 
less than or equal to 5.0 µm aerodynamic diameter. FPF is defined as the mass fraction of the delivered 
drug dose with less than or equal to 5.0 µm aerodynamic diameter and used to characterise the lung 
deposition and efficiency of DPI formulations for systemic pulmonary application (Kramek-
Romanowska et al., 2011; Depreter, Pilcer and Amighi, 2013; Ali and Gary, 2015; Peng et al., 2016; 
Mönckedieck et al., 2017). Particles collected from the low impactor stages (e.g., between 3 and 5) 
with less than or equal to 5.0 µm aerodynamic diameter generally represent the respirable-sized drug 
dose, whereas particles deposited in the higher impactor stages (e.g., throat and stage 1) represent 
the oropharyngeal deposition in the oropharynx region (Niwa, Mizutani and Danjo, 2012; Ali and Gary, 
2015). In order to achieve therapeutic efficacy, the size of drug particles should be respirable (MMAD 
≤5.0 µm) with low GSD indicating monodisperse particle size distribution to reach the desired deep 
lung regions for systemic pulmonary delivery and FPF should be high for drug aerosolisation efficiency 
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(Kramek-Romanowska et al., 2011; Maltesen, Weert and Grohganz, 2012; Walters et al., 2014; Yang, 
Chan and Chan, 2014; Rahimpour, Kouhsoltani and Hamishehkar, 2014; Ali and Gary, 2015; Banga, 
2015; Peng et al., 2016).  
However, the respirable-sized drug particles (MMAD ≤5.0 µm) are associated with high surface energy 
where inter-particulate forces are involved such as micronised drug to drug cohesive forces. It causes 
the drug particles to aggregate and leads to limited fluidisation and dispersion of the particles (Pilcer 
and Amighi, 2010; Ali and Gary, 2015; Berkenfeld, Lamprecht and McConville, 2015; Peng et al., 2016). 
Therefore, carriers (e.g., particle size 50-100 µm or larger up to 200 µm) regarded as key components 
in the development of DPI formulations are employed as a means of delivering the drug to the lungs 
and to improve the drug delivery efficiency (Kramek-Romanowska et al., 2011; Karner, Littringer and 
Urbanetz, 2014; Ali and Gary, 2015; Peng et al., 2016; Mönckedieck et al., 2017). Due to the safety 
concern about carriers to the lungs and insufficient toxicology data, the amount of carriers used should 
be minimised in DPI formulations to reduce adverse effects of carriers (e.g., cough) (Balducci et al., 
2014; Santos and Edelman, 2014; Al-Tabakha, 2015; Peng et al., 2016). Coarse carrier particles used in 
DPI formulations are designed not to reach the lungs and cleared by swallowing (Peng et al., 2016). 
Therefore, only the drug particles detached from the carriers during inhalation should be delivered to 
the deep lung regions (Peng et al., 2016). The evaluation study based on surrogate modelling 
technique of carrier physicochemical properties (e.g., particle size and surface morphology) reported 
by Farizhandi et al. (2019) showed that the presence of fine carrier particles (< 10 µm) could improve 
FPF (the efficiency of drug aerosolisation). However, inhalation of fine carrier particles might cause 
irritation, coughing or bronchoconstriction (Peng et al., 2016).  
 
Many analytical methods such as high performance liquid chromatography (HPLC), UV spectroscopy 
and gas chromatography (GC) have been employed to quantify saccharides (Schmid et al., 2016; Chiara 
et al., 2017). D’Addio et al. (2013) reported the quantification of mannitol deposition via the NGI 
studies using HPLC with a refractive index detector. However, with these analytical methods routine 
quantitative analysis of saccharide in the DPI formulation development can be limited due to the lack 
of chromophores in saccharides (Coombes et al., 2014; Schmid et al., 2016). Gas chromatography and 
UV spectroscopy involve several steps such as derivatisation to volatilise the compounds for GC and 
to convert saccharides to UV detectable saccharides (Schmid et al., 2016; Chiara et al., 2017). These 
methods are regarded as time-consuming. Although derivatisation steps are not required for HPLC, 
HPLC is associated with low detection sensitivity due to the lack of chromophores on sugars where 
specialised (and sometimes expensive) detectors are required (Chiara et al., 2017). On the contrary, 
1H qNMR offers advantages, such as relatively short analysis time and simple sample preparation 
(simple sample dissolution in a suitable NMR solvent) due to no derivatisation steps involved, and 
simultaneous analysis of multiple analytes with one internal standard (Holzgrabe, 2010; Bharti and 
Roy, 2012; Pauli et al., 2012; Hou et al., 2014; Simmler et al., 2014; Chiara et al., 2017). 1H qNMR 
measurements are also reproducible with high accuracy and precision (Bharti and Roy, 2012; Pauli et 
al., 2012; Sterling et al., 2013; Yamazaki and Takatsu, 2014; Schievano, Tonoli, and Rastrelli, 2017; 
Wallmeier et al., 2017).  
 
1H qNMR represents the direct proportional relationship between the intensity of the signal and the 
number of protons that gives rise to that signal in the proton NMR spectrum (Holzgrabe, 2010; 
Richards and Hollerton, 2011; Bharti and Roy, 2012; Günther, 2013; Simmler et al., 2014; Coombes et 
al., 2014; Hou et al., 2014; Yamazaki and Takatsu, 2014). Therefore, 1H qNMR is performed by 
comparing the integrated signals of the compound of interest with the signals of the internal standard 
where its structure and purity are known (Pauli et al., 2012; Simmler et al., 2014; Yamazaki and 
Takatsu, 2014) and have been employed in various areas. Quantification of saccharides (glucose, 
sucrose and fructose) in Açai raw materials using the absolute intensity qNMR method has been 
reported by Sterling et al. (2013) who demonstrated the accuracy and precision of the method. 
Quantification of avermectin B1a (macrolide antibiotic) in agriculture industry reported by Hou et al. 
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(2014) showed no significant difference between HPLC and 1H qNMR quantitation results.  Dissolution 
study using 1H NMR reported by Coombes et al. (2014) demonstrated high selectivity to quantify the 
mixture of three active drug substances and excipient (lactose) in oral immediate-release tablets with 
sufficient sensitivity in the low concentrations (6 µg mL-1 as maximum concentration). Identification 
and quantitation of sugars excipients (mannitol, sucrose, trehalose and lactose) in freeze-dried 
vaccines using Total Correlation Spectroscopy (TOCSY) 2D NMR techniques was reported by Duru et 
al. (2015). Schievano et al. (2017) reported 22 sugars (e.g., glucose, sucrose, and trehalose) that were 
present in honey samples prepared in buffer and were able to identify and quantify them using 
Chemical Shift Selective Filters TOCSY (CSSFs-TOCSY). The CSSFs-TOCSY technique proved to be an 
accurate and precise quantitative analytical tools with easy sample preparation. Although there are 
many precedents indicating the usefulness of NMR techniques, 1H qNMR is not routinely used in the 
quantification of saccharides in DPI formulations. So far, no studies reported the use of 1H qNMR to 
quantify the deposition of saccharides in pulmonary formulations. The aim of this study was to 
develop an analytical method using 1H NMR spectroscopy for quantitative analysis of saccharide 
deposition patterns. Spray drying and spray freeze drying using D-mannitol, D-sorbitol and D-(+)-
sucrose were employed to prepare saccharide dry powders as DPI carriers. Impaction studies were 
carried out employing a next generation impactor (NGI) with an Alberta Idealised Throat (AIT) to 
estimate the lung deposition patterns in vitro for saccharide DPI formulations.  
 
 
 
 
2. Materials and methods 
2.1. Materials 
D-mannitol (mannitol, purity 98%, Sigma-Aldrich), D-sorbitol (sorbitol, purity 98%, Sigma-Life Science), 
D-(+)-sucrose (sucrose, purity 99.7%, Acros Organics), sodium benzoate (purity 99%, Sigma-Aldrich), 
deuterium oxide (D2O, Euriso-top®), sodium 3-trimethylsilyl propionate-2,2,3,3-d4 (TSP, Merck Sharp 
& Dohme Canada Limited), and human recombinant insulin (Sigma-Aldrich).  
2.2. Spray drying  
Saccharides aqueous solutions (15% w/v) were prepared at room temperature and spray dried using 
a Büchi Mini Spray Dryer B-290 (Flawil, Switzerland) under the optimised processing parameters: 320 
mL hr-1 feeding rate, spray flow rate with compressed air between 473 and 601 L hr-1, 100% aspirator 
speed setting, inlet temperature at 130˚C and outlet temperature at 70±5˚C. Output pressure and 
receiver pressure were set to 4 and 8 bar, respectively.  
 
2.3. Spray freeze drying  
Saccharides aqueous solutions (15% w/v) were sprayed over a cryogenic medium composed of liquid 
nitrogen (LN2) in a 250 mL round bottom flask. The samples were freeze dried using BenchTop Pro 
with Omnitronics™ (SP Scientific, UK) for 48 hours at 55±5 µbar pressure and condenser temperature 
of -59 ± 2˚C.  
 
2.4. Morphology by scanning electron microscopy  
Morphology along with particle size of all three selected raw saccharides (mannitol, sucrose, and 
sorbitol), spray dried (SD) and spray freeze dried (SFD) mannitol and sucrose dry powders were 
characterised by scanning electron microscopy (SEM, ZEISS EVO®50, UK). Double-sided cohesive 
carbon tabs were adhered to aluminum stubs and all dry powder samples were placed onto the carbon 
tabs. Any excess powder samples were tapped off from the tabs. These samples were then coated 
with a palladium/gold alloy using a SC7640 Sputter Coater under Argon gas for 2 minutes. Multiple 
images of coated samples were then captured for each sample using SEM. 
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2.5. Particle size distribution by laser diffraction 
Particle size distribution of all three selected raw saccharides (mannitol, sucrose, and sorbitol), SD and 
SFD mannitol and sucrose dry powders was measured using a HELOS/BF laser diffraction system 
equipped with a Rodos dispenser (Sympatec GmbH, Clausthal-Zellerfeld, Germany) and vibratory 
feeding unit (VIBRI, Sympatec GmbH, Clausthal-Zellerfeld, Germany)  in the R3 measuring range from 
0.5/0.9 to 175 µm. The trigger condition for normal measurement under the standard mode was set 
to start after the “channel 21” was ≥1.0% and stop after the optimal concentration was ≤1.9% for 10 
sec real time or 60 sec trigger time out. The primary pressure was set to 1.0 bar. Sympatec WINDOX 
software was used to calculate volume median diameter (VMD).  
2.6. Thermogravimetric analysis 
Thermogravimetric analysis (TGA) for all three selected raw saccharides (mannitol, sucrose, and 
sorbitol), SD and SFD mannitol and sucrose dry powders was performed to measure moisture 
content using a METTLER TOLEDO TGA/DSC1 STARe System (Mettler Toledo, Switzerland). All dry 
powder samples weighted between 4.5 mg and 12.0 mg were loaded onto a pan and heated under 
nitrogen gas in the temperature range from 40  C̊ to 400  C̊. The TGA curves were recorded at room 
temperature in an inert atmosphere using STARe Software version 8.10. 
 
2.7. Pulmonary deposition study by next generation impactor  
Pulmonary deposition was studied using a NGI (Copley Scientific, Nottingham, UK) equipped with the 
Alberta Idealised Throat (AIT) 28028 designed for adult human upper respiratory tract geometry. The 
airflow of the NGI was adjusted to 30±0.5 L min-1 with 3 sec inspiration time. A leak test was performed 
on the NGI prior to each use. In this study, Handihaler® (Boehringer Ingelheim, Germany) was used to 
deliver the content of raw, SD and SFD saccharide dry powders filled using size 3 capsules (CAPSUGEL®, 
UK) during the impaction studies. The saccharide dry powders deposited on AIT and on all NGI stages 
(stages 1-7 and micro orifice collector, MOC) were collected, washing with distilled water (2 mL) and 
kept in glass vials in the refrigerator (2-8 °C) prior to 1H qNMR analysis. Saccharide dry powders 
deposited on AIT, 7 stages and MOC in the NGI were based on the aerodynamic cut-off diameters of 
0.541 µm (stage 7), 0.834 µm (stage 6), 1.357 µm (stage 5), 2.299 µm (stage 4), 3.988 µm (stage 3), 
6.395 µm (stage 2), and 11.719 µm (stage 1) at flow rate of 30 L min-1 with 3 sec inspiration time. All 
NGI studies were performed at room temperature and run in triplicate. Saccharide aerosolisation 
performance was assessed, using Microsoft Excel and Copley Inhaler Testing Data Analysis Software 
(CITDAS) Version 3.10 Wibu that meets the requirements of USP 32 and Ph.Eur.6.0, to determine the 
delivered dose expressed as a percentage of the total saccharide deposition on AIT and all the 
impactor stages, FPF, MMAD and GSD. The delivered dose was determined as the ratio of the total 
saccharide deposition on AIT and all the NGI stages excluding the deposition in the inhaler device and 
capsules to the total saccharide dose dispersed from the device including the deposition in the inhaler 
device and capsules (i.e. the mass of the saccharide filled into the capsule). In this study, FPF, MMAD 
and GSD determined were based on the saccharide deposition dose. 
 
 
2.8. NMR sample preparation 
Standard stock solutions of each of the three saccharides and internal standard (sodium benzoate) 
were prepared in distilled water at a concentration of 107.591 mM for mannitol and sorbitol, 58.255 
mM for sucrose, and 297.140 mM for sodium benzoate. Five to six serial dilutions were prepared and 
mixed with sodium benzoate; D2O was used as solvent spiked with TSP as the chemical shift reference 
material. Each solution (650 µL) was transferred into a 5 mm diameter NMR tube and analysed as 
described in the next section.  
NGI sample solutions for 1H qNMR were prepared by mixing D2O with TSP, sodium benzoate and each 
deposited powders collected from the NGI (AIT, all 7 stages of the NGI impactor and MOC) in ratios of 
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1:1:8, respectively. The concentration of internal standard was kept constant through all the NMR 
sample solutions. 
 
2.9. 1H NMR data measurement 
All 1H NMR measurements for standard calibration curves, validation experiments and NGI sample 
solutions were performed on a Bruker Avance III 600 NMR spectrometer (600.13MHz for 1H) equipped 
with a TXI 1H/2D{13C,15N} autotune room temperature probehead (Bruker UK Limited, Coventry, UK). 
Water suppression was achieved using that Bruker-supplied noesygppr1d (avance-version 12/01/11) 
pulse program which performs presaturation of the water signal during the relaxation delay and 
mixing time and further removes unwanted magnetisation artefacts using a spoil gradient. Acquisition 
parameters for all 1H NMR spectra were set as follows:  mixing time 10ms, number of scans 64, 
complex data points 64K for 12KHz spectral width giving an acquisition time of 2.66s. The receiver gain 
(RG) was limited to a maximum value of 128. In order to mitigate against possible differences in 
receiver gain within replicates run in automation, an internal standard was used to normalise integrals 
and thus alleviate integral discrepancies resulting from the non-linearity of the probehead amplifier. 
The internal standard selected had to be accurately weighed and its concentration was kept constant 
throughout the measurements. We used readily available sodium benzoate as its resonances were 
not influenced by the analyte’s peaks or the water signal. The internal standard was used purely an 
integral normalisation device. The relaxation delay (D1) was set to 4 seconds which overall afforded a 
repetition time = 6.7s, approx. 3 x T1 of the slowest relaxing analyte’s proton and approximately 1 x T1 
the slowest relaxing benzoate proton (T1 values data available in the supplementary information). 
Temperature was kept constant at 298.2K throughout the NMR measurements. All 1H NMR 
measurements were run in triplicate under the same parameters and conditions.  
 
2.10. NMR data processing 
All NMR data were processed using TopSpin 3.5pl7 (Bruker BioSpin GmbH, Rheinstetten, Germany) by 
applying a fast Fourier transform with an exponential apodisation window (line broadening of 0.2Hz) 
and zero filling to 64K real data points. The spectra were automatically referenced to internal TSP, 
automatically phase corrected with manual fine tuning of the phase as required, and automatically 
baseline corrected (using polynomial degree 5).  
 
2.11. 1H NMR quantitative analysis 
All the signals for the internal standard, sodium benzoate, and each saccharide were manually 
integrated. One of the peaks from the internal standard was chosen as the calibrant in all the spectra. 
After completion of manual integration, the integral values for the saccharides were normalised using 
the calibrant and a calibration curve was constructed for subsequent quantitative analysis of 
saccharide lung deposition in vitro. Calibration curves for three selected saccharides were constructed 
by plotting the known concentration of saccharide on the x-axis against the normalised integral values 
of the saccharide on the y-axis. Normalised integral values were calculated using equation 1:  
 
 Equation 1 
The magnetisation recovery afforded by a repetition rate of 6.7 second was found to afford a good 
sensitivity for the saccharides (~ 3 x T1 of slowest relaxing saccharide proton) and adequate sensitivity 
for the internal standard (~ 1 x T1 of slowest relaxing benzoate proton). The T1 measurement results 
are provided separately and summarised in Tables S2-S4 in the supplementary information. The 
internal standard was solely used to derive relative integral values for the saccharides. Although the 
  
7 
 
maximum sensitivity is not obtained for the analytes in those conditions, quantitative results were 
obtained, and the time saved thanks to a shorter acquisition allowed for faster sample throughput.  
 
2.12. Method validation  
1H qNMR method validation was carried out based on the International Council for Harmonisation of 
Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. The main objective was 
to demonstrate that the 1H qNMR analysis was suitable for the quantitation of the saccharide used in 
our DPI formulations. Validation characteristics, such as specificity, linearity and range, accuracy and 
precision along with limit of detection (LOD) and limit of quantitation (LOQ) were assessed. 
 
Specificity 
Specificity was evaluated using 1H NMR spectra of the three saccharides to see whether the signals of 
each saccharide, sodium benzoate and water were well separated from each other in all 1H NMR 
spectra. Whilst determining T1 values we saw no significant changes in peak position, resolution, and 
T1 values when measuring the analyte alone (in deuterium oxide) or in the presence of sodium 
benzoate or insulin (used as model compound) in a similar concentration to those used in the 
calibration curves (supplementary information, Figures S1 – S7). 
 
Linearity and Range 
The linearity of the 1H qNMR method was evaluated by preparing the calibration curves for a series of 
5-6 concentrations of selected saccharides. The concentrations ranges were 1.352-21.636 mM for 
mannitol, 1.351-21.615 mM for sorbitol, and 0.729-23.314 mM for sucrose. Linear regression analysis 
was used to evidence the direct proportional relationship between the signal intensity and the number 
of protons. The correlation coefficient (R2) and the regression equation (y intercept and slope of the 
regression line) were computed.  
 
Accuracy / Trueness 
The accuracy, which is also termed trueness, of the 1H qNMR method was assessed by measuring three 
concentrations (low, middle and high end of the calibration curve concentration range) in three 
replicates. The accuracy of the measurements was reported as the difference (bias%, relative error%) 
between the measured concentration (mc) and nominal concentration (nc) of each saccharide of 
interest, using the equation: (mc-nc) x 100/nc provided by Schievano et al. (2017). 
 
Precision 
The intra-day precision was assessed by calculating the standard deviation (SD) and relative standard 
deviation (RSD%) of the above replicated measurements (three different concentrations/three 
replicates each on the same day). The inter-day precision of the 1H qNMR method in the same 
laboratory, under the same measurement conditions, was assessed by replicating the same 
measurements each day for three days. The SD and RSD% of the nine NMR data acquisitions per 
concentration were calculated.  
 
Limit of detection and limit of quantitation  
The LOD (defined as “the lowest amount of analyte in a sample that can be detected but not 
necessarily quantitated”) and LOQ (defined as the lower limit of precise and accurate quantitative 
measurements) were calculated at the 95% confidence level using “Regression statistics analysis” in 
Excel. The ICH guidelines equations were used: LOD= 3.3*σ/S and LOQ=10*σ/S, where σ is the 
standard deviation of the response and S is the slope of the calibration curve. 
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3. Results and discussion 
3.1. Physicochemical Characterisation  
Prior to quantifying the three saccharides using 1H qNMR, the morphology, particle size, and moisture 
content of the raw, SD and SFD dry powders were characterised using SEM, laser diffraction and TGA. 
Raw sucrose was milled in order to reduce the particle size within the carrier particle size range. 
Mannitol and sucrose dry powders were successfully prepared as DPI carriers using SD and SFD and 
characterised. Sorbitol aqueous solution (15% v/w) failed to produce dry powders using SD, which 
resulted in clear paste formation due to the inlet temperature used at 130 °C (above sorbitol melting 
point of around 100 °C (Nezzal et al., 2009)). SFD also failed to produce sorbitol dry powders as DPI 
carrier resulting in collapse due to the primary drying process taking place at room temperature that 
was above glass transition temperature of sorbitol. Due to the failure of SD and SFD powder 
formations for sorbitol, physicochemical characterisation was carried out only for raw sorbitol in this 
study.  
 
3.1.1. Morphology by Scanning Electron Microscopy  
Different morphologies in all mannitol dry powder samples were observed (Figure 1). The SEM image 
of raw mannitol (Figure 1A) showed elongated particles with rather rough surface. It was observed 
that SD and SFD methods modified the size and surface morphology of mannitol particles. In contrast 
to SD mannitol powders, the resultant SFD mannitol powders were very fluffy.The SEM image of SFD 
mannitol (Figure 1B) showed spherical and highly porous particles with large particle size ranging 
between 50-110 µm, which is within the suitable carrier size range (50-100 µm or larger up to 200 µm 
as described in introduction). However, some small fragments of the porous particles were also 
observed and resulted in the broad particle size distribution with the high span value discussed later 
in section 3.1.2.   On the contrary, the SEM image of SD mannitol (Figure 1C) showed spherical particles 
with smooth surface in the smaller particle size range of 2-10 µm. Spherical particles with smooth 
surface produced by SD could be due to the conversion of feed solution to droplets exposed to hot 
compressed air. This leads to instant solvent evaporation and droplets formation with coated surface 
layer (Razavi Rohani, Abnous and Tafaghodi, 2014).  
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Figure 1: SEM images of dry powders of (A) raw mannitol, (B) spray freeze dried (SFD) mannitol and (C) 
spray dried (SD) mannitol. 
 
 
Analogously to mannitol, different morphologies in all sucrose dry powder samples were observed 
(Figure 2). Raw sucrose was elongated particles with rather rough surface in the particle size range of 
4-130 µm (Figure 2A). On the other hand, SFD sucrose (Figure 2B) showed aggregated particles with 
smooth surface composed of some spherical and irregular shape particles fusing together. This was 
due to the aggregation occurred during the process of spraying aqueous saccharide samples over LN2 
and during the primary drying. SD particles also showed aggregation with smooth surface composed 
of spherical particles fusing together resulting in particles with irregular shape (Figure 2C). Despite the 
smooth surface observed for both SFD and SD sucrose, the resultant SFD sucrose powders were rather 
fluffy compared to SD sucrose powders. Nonetheless, it was observed that SFD produced some 
spherical particles with a suitable carrier particle size range of 50-100 µm (Figure 2B) whereas SD 
method produced spherical particles with the smaller particle size range of 20-100 µm (Figure 2C). 
Raw sorbitol formed irregular particles with fibrous and rather rough surface in the particle size range 
of 15-150 µm (Figure 2D). SEM images showed various morphologies overall and the particle size for 
all saccharide dry powders varied with the method of dry powder preparation in the following rank 
order:  raw > SFD > SD. 
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A.                                                                       B. 
   
C.              D. 
                                                 
Figure 2: SEM images of dry powders of (A) raw sucrose, (B) spray freeze dried (SFD) sucrose, (C) spray 
dried (SD) sucrose and (D) raw sorbitol. 
 
 
3.1.2. Particle size distribution by laser diffraction 
The particle diameters (µm) at 10%, 50% and 90% of the volume distribution for raw saccharides 
(mannitol, sucrose, and sorbitol), SFD and SD mannitol and sucrose dry powders are presented in 
Table 1. The results of laser diffraction in Table 1 showed that raw saccharides had the largest 
Volume Mean Diameter (VMD) followed by SFD saccharides and SD saccharides had the smallest 
VMD in the following rank order: raw sorbitol > raw sucrose > raw mannitol > SFD sucrose > SFD 
mannitol > SD mannitol > SD sucrose.  Particle size measurement by laser diffraction also showed 
that both methods SFD and SD modified the particle size of saccharide dry powders and supported 
the SEM images (Figure 1 and 2). The span values were in the rank order of SFD mannitol > SFD 
sucrose > raw sucrose > raw mannitol > SD sucrose > SD mannitol > raw sorbitol. This represented 
that raw sorbitol had the most narrow size distribution with the lowest span value (1.29), whereas 
SFD mannitol had the highest span value of above 10 indicating polydispersity due to the presence 
of some small fragments of the porous particles observed by the SEM image (Figure 1B).  This might 
have led to the saccharide particle deposition in the lower NGI stages (discussed later in pulmonary 
deposition). SD saccharides showed narrower particle distribution with the smaller span values 
compared to their raw and SFD saccharides. As discussed in introduction, particle size distribution 
affects the deposition pattern in the respiratory system and coarse carrier particles used in DPI 
formulations should not reach the lungs; therefore, monodisperse size distribution is desirable for 
carriers targeting the oropharynx region. Broad particle distribution would lead to variations in the 
deposition pattern in the targeted regions. 
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Table 1: Particle size volume diameters (µm) at 10% (Dv10), 50% (Dv50) and 90% (Dv90) of the volume 
distribution for raw saccharides (mannitol, sucrose, and sorbitol), spray freeze dried (SFD) mannitol and 
sucrose, and spray dried (SD) mannitol and sucrose dry powders. 
Saccharide Dv10 (µm) Dv50 (µm) Dv90 (µm) VMD (µm) 
Span 
(Dv90 - Dv10/ Dv50) 
Raw mannitol 8.87 42.32 103.97 50.20 2.25 
SFD mannitol 1.62 10.34 113.37 34.83 10.81 
SD mannitol 1.05 4.77 10.87 5.54 2.06 
Raw sucrose 4.14 48.98 121.79 56.44  2.40 
SFD sucrose 2.62 25.47 99.01 40.11 3.78 
SD sucrose 0.87 3.45 8.57 4.17 2.23 
Raw sorbitol 17.54 107.59 156.50 94.96 1.29 
 
3.1.3. Thermogravimetric analysis 
Moisture content in raw, SFD and SD saccharide dry powders was measured by TGA. The TGA results 
in Figure 3a showed that the weight loss was observed in SFD mannitol (5.5%) and SD mannitol (2.0%) 
below 70 °C where water evaporation would have taken place whereas there was no mass change 
observed for raw mannitol. It was also observed that SFD and SD sucrose exhibited weight loss (7.5% 
and 3.0%, respectively) whereas raw sucrose showed no mass changes (Figure 3b). This indicates that 
SFD and SD methods produced hygroscopic saccharide formulations compared to raw saccharides 
(mannitol and sucrose). In contrast to the SD formulations, the higher moisture content was observed 
in the SFD formulations and this could be linked to the drying process which is not as efficient as the 
SD which showed lower moisture content. Raw sorbitol is considered as hygroscopic compound due 
to the weight loss of about 4.0% observed in the TGA result (Figure 3a) compared to raw mannitol and 
raw sucrose. 
 
a          b 
 
Figure 3: Thermogravimetric analysis (TGA) thermograms of (a) raw mannitol, spray freeze dried (SFD) 
mannitol, spray dried (SD) mannitol, and raw sorbitol, (b) raw sucrose, spray freeze dried (SFD) sucrose 
and spray dried (SD) sucrose dry powders. 
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3.2. Quantitative proton NMR  
3.2.1. Experimental parameters and water suppression  
In this study, processing parameters (e.g., signal to noise ratio (S/N)) and acquisition parameters such 
as number of scans, acquisition time and receiver gain (RG) were pre-optimised as these parameters 
affect the accuracy and precision of the measurement (Bharti and Roy, 2012). Setting RG to 128 and 
the number of scans to 64 allowed us to achieve S/N of 250:1 or better (Holzgrabe, 2010; Bharti and 
Roy, 2012). Acquisition time was 2.656 sec and the relaxation delay was set to 4.000 sec to allow 
satisfactory relaxation of the protons between pulses (Holzgrabe, 2010; Roberts and Lian, 2011). 
Temperature, which is known to affect chemical shifts and integration (Bharti and Roy, 2012; Yamazaki 
and Takatsu, 2014) was kept constant at 298.2K throughout the measurements. 1H qNMR 
measurements were carried out using water suppression for accurate and precise quantification of 
the signals of interest (Hore, 1983; Holzgrabe, 2010; Richards and Hollerton, 2011; Bharti and Roy, 
2012; Coombes et al., 2014; Giraudeau, Silvestre and Akoka, 2015). 
 
3.2.2. Method validation  
Quantitative analysis was carried out by comparing the integrated signals of the saccharide of interest 
with sodium benzoate as an internal standard. Sodium benzoate was chosen as an internal standard 
as it shows no interference with saccharides and its peaks are well resolved (known requirements for 
q-NMR) (Holzgrabe, 2010; Bharti and Roy, 2012; Pauli et al., 2012). Sodium benzoate also dissolves 
well in D2O, and although it is hygroscopic at humidity above 50%, under normal weighing conditions 
in an enclosed accurate balance, in our hands it did not pickup significant amount of water.  
The reference compound and internal standard were directly added to the saccharide in the same 
NMR tube and dissolved well in deuterated NMR solvent. Figure 4 shows the 1H NMR spectra of 
sodium benzoate and the three saccharides dissolved in H2O/D2O with the integral regions selected 
for quantification. The signals of sodium benzoate were manually integrated in the range of 7.457-
7.905 ppm (Figure 4a) and the signal at 7.87 ppm (Figure 4a, HA and HE protons, multiplet, T1 = 6.3s) 
was selected as internal calibrant peak. The signals of each saccharide were manually integrated in 
the range of 3.655-3.906 ppm for mannitol (Figure 4b), 3.551-3.900 ppm for sorbitol (Figure 4c) and 
3.440-4.247 ppm and 5.396-5.432 ppm for sucrose (Figure 4d).  
 
 
 
 
a  
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b         c 
     
 
d  
 
 
Figure 4: 1H NMR spectra of (a) sodium benzoate with peak assignments, (b) mannitol, (c) sorbitol, and (d) 
sucrose in H2O/D2O (90:10) with the integral regions selected for quantification.  
 
 
Specificity 
The signals of each saccharide, sodium benzoate and water around 4.80 ppm did not overlap in any 
of the 1H NMR spectra (Figure 5) which allowed unequivocal integration of the signals of interest.  
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Figure 5: 1H NMR spectra multiple displays of saccharide samples (mannitol, sucrose, and sorbitol) 
dissolved in distilled water in the presence of internal standard of sodium benzoate. TSP: Sodium 3-
trimethylsilyl propionate-2,2,3,3-d4. 
 
 
Linearity and Range 
The linearity was determined by regression analysis that generated linear correlation coefficient (R2) 
and regression equation with five or six different concentrations (Table 3). The calibration curves 
constructed for all three saccharides were linear with R2 value of 1.0000 (Figure 6a). This showed, as 
expected, that the integral value was proportional to concentration within the range of concentrations 
chosen. Regression analysis for the determination of correction factors demonstrated no discrepancy 
as the measured concentration (y-axis) was almost as equal to the nominal concentration (x-axis) 
(Figure 6b and Table 3). 
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Figure 6a: Calibration curves for mannitol, sucrose and sorbitol. 
 
 
 
 
 
Figure 6b: Correction factors between nominal concentration (mM) and measured concentration (mM) for 
mannitol, sucrose and sorbitol. 
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Accuracy and Precision 
The accuracy and precision of the 1H qNMR method was assessed at three different concentrations. 
Table 2 shows that relative error (%) for mannitol, sucrose and sorbitol were all less than 3.697%. SD 
and RSD% values determined for the three saccharides were all below 0.389 and below 3.126, 
respectively. These results demonstrated that the 1H qNMR method produced accurate (bias % 
<3.697) and precise data with high repeatability (RSD % <3.126) with linear relationship over the 
concentration range used.
 
 
Table 2: Results of relative error (%), intra-day precision (three different concentrations / three 
replicates each on the same day) and inter-day precision (9 NMR data acquisitions per concentration 
over 3 days) validation study for the determination of mannitol, sucrose and sorbitol. Data presented as 
mean measured concentration (mM) with standard deviation (SD), relative standard deviation (RSD%) 
and relative error% (bias%). 
Saccharide 
Nominal 
concentration 
(mM) 
Mean measured 
concentration 
(mM) 
SD RSD (%) 
Relative 
error (%) 
(bias %)  
Intra-day precision 
Mannitol 
21.529 21.599 0.061 0.281 0.328 
5.382 5.449 0.025 0.464 1.234 
1.346 1.383 0.007 0.497 2.760 
Sucrose 
23.302 23.611 0.198 0.841 1.327 
5.825 5.880 0.020 0.338 0.940 
0.728 0.728 0.013 1.748 -0.054 
Sorbitol 
21.540 21.341 0.094 0.440 -0.924 
5.385 5.384 0.040 0.743 -0.014 
1.346 1.364 0.015 1.080 1.350 
Inter-day precision 
Mannitol 
21.529 21.568 0.112 0.517 0.184 
5.382 5.450 0.065 1.197 1.255 
1.346 1.395 0.011 0.789 3.697 
Sucrose 
23.302 23.962 0.389 1.625 2.831 
5.825 6.016 0.121 2.018 3.264 
0.728 0.741 0.023 3.126 1.755 
Sorbitol 
21.540 21.072 0.248 1.176 -2.173 
5.385 5.383 0.044 0.815 -0.045 
1.346 1.378 0.013 0.932 2.376 
 
 
 
Limit of detection (LOD) and limit of quantitation (LOQ) 
LOD and LOQ values for all three saccharides are presented in Table 3. The results of LOD and LOQ 
show that the 1H qNMR method demonstrated significant sensitivity with low values of LOD (0.058 
mM for mannitol, 0.045 mM for sucrose, and 0.056 mM for sorbitol) and LOQ (0.175 mM for mannitol, 
0.135 mM for sucrose, and 0.168 mM for sorbitol). This indicates that concentrations determined from 
the linear concentration range of the calibration curves were both within LOD and LOQ. 
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Table 3: Linear correlation coefficient (R2), regression equation, limit of detection (LOD) and limit of 
quantitation (LOQ) 
Saccharide 
Regression equation 
for calibration curve 
R2 
LOD 
(mM) 
LOQ 
(mM) 
Regression equation 
for correction factor 
Mannitol y = 0.0417x - 0.0009 1.0000 0.058 0.175 y = 0.9991x - 0.0000 
Sucrose y = 0.0394x + 0.0014 1.0000 0.045 0.135 y = 1.0009x + 0.0008 
Sorbitol y = 0.0421x - 0.0007 1.0000 0.056 0.168 y = 0.9993x + 0.0005 
 
 
 
3.3. Pulmonary deposition study and saccharide quantification 
The impaction study was carried out using a NGI equipped with an AIT 28028 in order to determine 
the amount of all three selected raw saccharides (mannitol, sucrose, and sorbitol) and SFD and SD 
dry powders composed of mannitol and sucrose deposited on AIT and all NGI stages using the 
calibration curve constructed by 1H qNMR analysis (Figure 6a).  
In this study, with the exception of SD mannitol, six saccharide carrier formulations (raw mannitol, 
SFD mannitol, raw sucrose, SFD sucrose, SD sucrose and raw sorbitol) with over 50% of the cumulative 
mass deposited on AIT and stage 1 of the NGI with 11.719 µm cut-off diameter, whereas below 50% 
of the total particles by mass deposited on between stage 2 with 6.395 µm cut-off diameter and stage 
7 with 0.541 µm cut-off diameter and MOC in the NGI (Figure 7). Therefore, MMAD was reported as 
NA (no available values for one side of the 50% MMAD) and consequently GSD was reported as NA 
(Table 4). On the other hand, SD mannitol generated MMAD of 5.778 ± 0.348 µm (Table 4) as SD 
mannitol dry powders also deposited on the NGI stages between 2 and MOC. This could be due to the 
small particles prepared by SD (2-10 µm by SEM and 5.54 µm VMD by laser diffraction). However, 
there was no significant difference in the deposition pattern in AIT and stage 1 (representing the 
oropharynx region) between all saccharide formulations (one-way ANOVA, p>0.05). In contrast to the 
deposition pattern in AIT and stage 1, particles deposition with below 6.395 µm cut-off diameter 
(stage 2) was dependent on the method of dry powder preparation that represented a significant 
difference in deposition patterns in the lower NGI stages (one-way ANOVA, p<0.05). This could be due 
to the various particle size and morphologies observed (Figure 1 and 2 and Table 1) that affected the 
powder deposition pattern.  
FPF (aerodynamic diameter ≤5.0 µm) based on the saccharide deposition dose was determined for SD 
mannitol (23.714±3.659%), SFD mannitol (11.386±0.760%) and raw sucrose (1.537±0.443%) (Table 4) 
with high cumulative fraction between stage 3 and 5 (Table 5) where generally represents the desired 
deep lung regions for systemic pulmonary delivery.  This presents that SD mannitol, SFD mannitol and 
raw sucrose dry powders would likely reach the lungs in vivo due to the presence of fine particles 
(aerodynamic diameter ≤5.0 µm) and could lead to the safety concern or alternatively could facilitate 
the efficiency of drug aerosolisation as mentioned in introduction. SD mannitol showed higher FPF 
than SFD mannitol indicating that higher amounts of mannitol dry powders prepared by SD deposited 
on the lower NGI stages compared with mannitol dry powders prepared by SFD. This represents that 
more SD dry powders would be expected to reach the lungs. However, raw mannitol, SFD sucrose, SD 
sucrose and raw sorbitol generated no FPF values reported by the NGI software (Table 4) due to a 
coarse-narrow distribution that over 50% of the cumulative mass deposited on AIT and stage 1 
(>11.719 µm) and cumulative fraction of saccharide deposited on the lower NGI stages (2-7) was less 
than 1% per stage or only one stage had a cumulative fraction over 1% (i.e., 1.19% for raw mannitol) 
(Figure 7 and Table 5). This represents that these four different saccharide dry powders exhibited the 
oropharyngeal deposition in the oropharynx region, which is advantageous as DPI carriers. The 
delivered dose was in the order of raw sorbitol (69.93%) > SFD mannitol (68.99%) > SFD sucrose 
(66.62%) > SD sucrose (57.70%) > raw mannitol (57.25%) > SD mannitol (49.03%) > raw sucrose 
(43.35%) (Table 4).  In this study, SFD mannitol and SFD sucrose with high moisture content (5.5% and 
7.5%, respectively) exhibited better delivered dose than SD mannitol and SD sucrose with lower 
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moisture content (2% and 3%, respectively) (Table 4 and Figure 3). This indicated that the saccharide 
flowability was not dependent on the moisture content.  Dry powders prepared as DPI carriers by SFD 
exhibited better flowability than dry powders prepared by SD. This could be due to the porous and 
fluffy particles produced by SFD that would have reduced inter-particulate forces resulting in better 
fluidisation (D’Addio et al., 2013; Rahimpour, Kouhsoltani and Hamishehkar, 2014; Weers and Miller, 
2015). Raw sorbitol exhibited the highest delivered dose with 69.93% among raw saccharides (57.25% 
for raw mannitol and 43.35% for raw sucrose). Raw mannitol exhibited higher delivered dose 
compared to SD mannitol. This could be due to the rough surface observed by SEM (Figure 1A and 2D) 
that would have been associated with reduced inter-particulate cohesive forces. The in vitro 
pulmonary deposition study demonstrated that SD and SFD produced saccharide dry powders with 
different deposition. The SFD method for saccharide dry powders preparation as DPI carriers seems 
to be more advantageous than SD as SFD exhibited higher delivered dose than SD. 
 
 
 
Table 4: Delivered dose (%), fine particle fraction (FPF ≤5.0 µm), mass median aerodynamic diameter 
(MMAD) and geometric standard deviation (GSD) of raw mannitol, spray dried (SD) mannitol, spray freeze 
dried (SFD) mannitol, raw sucrose, spray dried (SD) sucrose, spray freeze-dried (SFD) sucrose and raw 
sorbitol dry powders assessed by Next Generation Impactor analysis at flow rate of 30±0.5 L min-1. (Data 
presented as mean ± standard deviation, n=3) 
 
 Dose Size distribution 
Saccharide carrier 
formulation 
Delivered dose 
(%) 
FPF (%)  MMAD (µm)  GSD  
Raw mannitol 57.25 0 NA NA 
SD mannitol 49.03 23.714 ± 3.659 5.778 ± 0.348 2.106 ± 0.081 
SFD mannitol 68.99 11.386 ± 0.760 NA NA 
Raw sucrose 43.35 1.537 ± 0.443 NA NA 
SD sucrose 57.70 0 NA NA 
SFD sucrose 66.62 0 NA NA 
Raw sorbitol 69.93 0 NA NA 
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Figure 7: Particle size distribution by Next Generation Impactor (NGI) analysis at flow rate of 30±0.5 L min-
1 for raw mannitol, spray dried (SD) mannitol, spray freeze dried (SFD) mannitol, raw sucrose, spray dried 
(SD) sucrose, spray freeze dried (SFD) sucrose and raw sorbitol. Saccharide deposition is expressed as 
delivered dose (%) per NGI stage. (Data presented as mean ± standard deviation, n=3) AIT: Alberta idealised 
throat, MOC: Micro orifice collector. 
 
 
 Table 5: Cumulative fraction (%) of raw mannitol, spray dried (SD) mannitol, spray freeze dried (SFD) 
mannitol, raw sucrose, spray dried (SD) sucrose, spray freeze dried (SFD) sucrose and raw sorbitol 
deposited on Next Generation Impactor (NGI) stages (1-7). Cumulative fraction per NGI stage was 
calculated by the Copley Inhaler Testing Data Analysis software based on summation of the cumulative 
mass collected on NGI stages (1-7 and MOC, Alberta idealised throat is not included). (Data presented as 
mean, n=3)    
 Cumulative fraction (%) 
NGI Stage 
(Cut-off 
diameter) 
Raw 
Mannitol 
SFD 
Mannitol 
SD 
Mannitol 
Raw 
Sucrose 
SFD 
Sucrose 
SD 
Sucrose 
Raw 
Sorbitol 
1 
(11.719 
µm) 
2.87 34.03 74.78 6.71 1.10 2.51 0.90 
2 
(6.395 µm) 
1.19 20.40 55.65 4.34 0.16 0.34 0.51 
3 
(3.988 µm) 
0.78 11.37 31.53 2.58 0.00 0.00 0.42 
4 
(2.299 µm) 
0.60 4.71 10.74 0.82 0.00 0.00 0.34 
5 
(1.357 µm) 
0.41 1.64 2.78 0.00 0.00 0.00 0.26 
6 0.25 0.63 0.88 0.00 0.00 0.00 0.17 
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
45.00
50.00
AIT 1 2 3 4 5 6 7 MOC
Sa
cc
h
ar
id
e 
D
e
p
o
si
ti
o
n
 (
 %
)
NGI Stage
Raw Mannitol
SD Mannitol
SFD Mannitol
Raw Sucrose
SD Sucrose
SFD Sucrose
Raw Sorbitol
  
20 
 
(0.834 µm) 
7 
(0.541 µm) 
0.13 0.27 0.39 0.00 0.00 0.00 0.09 
 
 
 
4. Conclusion 
The 1H qNMR method was developed to quantify saccharides employed in DPI formulations and 
produced accurate and precise data with high repeatability within the calibration curve concentration 
range. The present study demonstrated the quantification of the three saccharide DPI carriers (raw, 
SFD and SD) using the developed 1H qNMR method and the lung deposition patterns in vitro for 
saccharide DPI carriers were assessed based on the amount of deposited saccharide quantified at each 
stage of the NGI. There was a significant difference in deposition patterns in the lower NGI stages 
(stage 2, <6.395 µm cut-off diameter) between all saccharide formulations. These differences could 
be due to the various particle size and morphologies observed with the use of different methods of 
dry powder preparation (raw, SFD and SD) that affected the powder deposition pattern. In contrast to 
the deposition patterns in the lower NGI stages, there was no significant difference in the deposition 
pattern in AIT and stage 1 (representing the oropharynx region) between all saccharide formulations. 
In this study, raw mannitol, SD sucrose, SFD sucrose and raw sorbitol exhibited the oropharyngeal 
deposition in the oropharynx region, which is advantageous as DPI carriers whereas SD mannitol, SFD 
mannitol and raw sucrose dry powders would likely reach the lungs in vivo due to the presence of fine 
particles (aerodynamic diameter ≤5.0 µm). SFD mannitol showed the particle deposition both in the 
oropharynx region and deep lung regions for systemic pulmonary delivery due to high span value. SD 
D-mannitol showed higher FPF than SFD D-mannitol. This was measured by the NGI depositions 
studies where 1H qNMR showed that higher amounts of SD mannitol dry powders deposited on the 
lower NGI stages compared with SFD mannitol dry powders. So it can be estimated that more SD 
saccharide dry powders would be expected to reach the lungs. It was found that the saccharide 
powder flowability was not dependent on the moisture content as SFD mannitol and SFD sucrose with 
high moisture content exhibited better delivered dose than SD mannitol and SD sucrose with lower 
moisture content. This could be due to the porous (and fluffy) particles produced by SFD. The 
developed 1H qNMR methodology can be used as an analytical method to assess pulmonary 
deposition in impaction experiments of saccharides employed as carriers in DPI formulations and 
ensure avoidance of saccharides deep deposition in lung. 
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